By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Astellas Pharma Inc. 

3-11 Nihonbashi-Honcho 2-chome

Chuo-ku  Tokyo  103-8411  Japan
Phone: 81-3-3244-3000 Fax: 81-3-3244-3272





Gilead (Durham, NC) 

Company News
Astellas (ALPMY) Announces Results From The First Head To Head Study Comparing QUTENZATM (Capsaicin 8% Patch) With Current Standard Of Care In Patients With Peripheral Neuropathic Pain 11/19/2015 10:55:00 AM
Astellas (ALPMY) Named A Best Place To Work For Lesbian, Gay, Bisexual And Transgender Equality For Second Consecutive Year 11/18/2015 10:37:47 AM
Astellas (ALPMY) Announces New Data To Be Presented At The 2015 American Society of Hematology Annual Meeting 11/17/2015 10:15:20 AM
Astellas (ALPMY) Appoints Peter Sandor To Vice President, Oncology Therapeutic Area Head For Marketing Strategy 11/13/2015 8:22:57 AM
LEO Pharma Puts Up €675 Million for Astellas (ALPMY)'s Global Dermatology Biz 11/11/2015 6:13:07 AM
Astellas (ALPMY) Snaps Up Stem Cell Pioneer Ocata in $379 Million Deal 11/10/2015 6:07:58 AM
Astellas (ALPMY) Promotes Doug Geiger To Vice President, Head Of New Therapeutic Areas In Marketing Strategy 10/28/2015 8:04:54 AM
Astellas (ALPMY) Inititaties Phase 3 Registration Trial Of gilteritinib (ASP2215) In Relapsed Or Refractory Acute Myeloid Leukemia Patients 10/28/2015 7:39:10 AM
ClearPath Development Launches Second Vaccine Company Under Strategic Partnership With Astellas Pharma 10/26/2015 10:27:04 AM
Affinivax Announces Collaboration With ClearPath And Astellas (ALPMY) To Develop Vaccines To Prevent Nosocomial Infections 10/26/2015 8:03:13 AM